JAMES LEKAS: Open Payments
NPI 1043205388 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,422 in 76 payments from 13 companies in 2025. Trend: 2023 $2,029 · 2024 $2,467 · 2025 $2,422
Food & beverage: $2,422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $535 |
| GENZYME CORPORATION | 12 | $490 |
| Regeneron Healthcare Solutions, Inc. | 14 | $393 |
| Incyte Corporation | 4 | $179 |
| Novartis Pharmaceuticals Corporation | 9 | $178 |
| Organon LLC | 2 | $160 |
| Galderma Laboratories, L.P. | 3 | $155 |
| Janssen Biotech, Inc. | 2 | $142 |
| Amgen Inc. | 3 | $62 |
| UCB, Inc. | 3 | $48 |
Products named: DUPIXENT, RINVOQ, Opzelura, VTAMA, NEMLUVIO, TREMFYA, COSENTYX, SKYRIZI.
Industry payments across GA — which companies pay providers there.
